New perspectives for a well-known biogenic amine: mast cell-derived histamine as pathophysiological agent in vincristine-induced neuropathic pain Erich H. Schneider Editorial 19 September 2017 Pages: 1085 - 1086
Pharmacological investigations on mast cell stabilizer and histamine receptor antagonists in vincristine-induced neuropathic pain Amteshwar Singh JaggiGunjanpreet KaurNirmal Singh Original Article 15 September 2017 Pages: 1087 - 1096
Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats Shih-Hsiang LoYingxiao LiHo-Shan Niu Original Article 30 July 2017 Pages: 1097 - 1104
Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species Fatma MouniebLaila RamadanAmany Balah Original Article 31 July 2017 Pages: 1105 - 1115
Calcineurin inhibitors regulate fibroblast growth factor 23 (FGF23) synthesis Ludmilla BärClaudia GroßmannMichael Föller Original Article 31 July 2017 Pages: 1117 - 1123
A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo Barbara MayerSvetlana KarakhanovaAlexandr V. Bazhin Original Article 04 August 2017 Pages: 1125 - 1134
T3 peptide, a fragment of tumstatin, stimulates proliferation and migration of cardiac fibroblasts through activation of Akt signaling pathway Jumpei YasudaKana FukuiHideyuki Yamawaki Original Article 07 August 2017 Pages: 1135 - 1144
Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway Noha A. T. AbbasSoad L. Kabil Original Article 05 August 2017 Pages: 1145 - 1153
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model Gerrit FrommeyerAndré MittelstedtLars Eckardt Original Article 06 August 2017 Pages: 1155 - 1161
Anti-nociceptive effect of stigmasterol in mouse models of acute and chronic pain Cristiani Isabel Banderó WalkerSara Marchesan OliveiraGabriela Trevisan Original Article 18 August 2017 Pages: 1163 - 1172
Siglec-8 as mast cell selective target: developing paradigms amidst inconvenient truths Gerhard J. Molderings Brief Communication 14 September 2017 Pages: 1173 - 1175